Video

Adil Harroud, MD

Publish date: February 9, 2018

At the ACTRIMS 2018 Forum, Dr. Harroud describes his investigation of the potential link between age at puberty onset and risk of MS.


 

Recommended Reading

VIDEO: Oral ozanimod shows promise for relapsing MS
ICYMI Multiple Sclerosis
Switching RRMS patients to daclizumab beta appears safe
ICYMI Multiple Sclerosis
Third course of alemtuzumab can improve MS outcomes
ICYMI Multiple Sclerosis
VIDEO: Managing the alemtuzumab paradox
ICYMI Multiple Sclerosis
MS: Past, Present, and Future
ICYMI Multiple Sclerosis
Rituximab May Provide Greater Benefits Than Other First-Line MS Therapies
ICYMI Multiple Sclerosis
MAGNIMS and McDonald Criteria Have Similar Accuracy
ICYMI Multiple Sclerosis
Trial of clozapine, risperidone halted in MS
ICYMI Multiple Sclerosis
‘Real-world evidence’ used to compare agents for relapsing-remitting MS
ICYMI Multiple Sclerosis
VIDEO: Advanced practice providers take on many roles in MS care
ICYMI Multiple Sclerosis